Prioritize investigators based on experience, enrollment performance, capacity and patient access.
Compare forecasted enrollment rates and study timelines using proprietary performance data.
Benchmark comparable trials and identify active studies targeting the same patient population.
investigators
sites globally
countries
clinical trials
Grounded in Citeline's curated trial, site, and investigator data, harmonized into one decision-ready foundation.
A clinical-trial-specific algorithm built with subject-matter and industry experts.
Trace every recommendation to the source data behind it, verified directly in Sitetrove and Trialtrove.
Configure how experience, capacity, recruitment, competition, and patient pool influence recommendations for your study.
50+ analysts maintain accuracy across 20+ years of clinical intelligence, supported by extensive global coverage.
Carry insight across the SmartSolutions workflow, from protocol design to cohort planning to investigator selection.
Evaluate investigators using experience, recruitment potential, capacity and patient access, with visibility into the factors behind every recommendation.
Surface qualified investigators you may otherwise have overlooked, including emerging and underutilized candidates with relevant experience and enrollment potential. Adjust matching strictness by disease, patient segment and phase to widen or tighten the pool.
Validated across 16,000+ back-tested trials.
Trial, site and investigator intelligence built on 20+ years of research.
Enrollment and execution signals across 60+ countries.
See the evidence behind every recommendation.
| Capability | Traditional Site Selection | Investigator SmartSelect |
|---|---|---|
| Search investigator and site trial history | ||
| Review past performance of known sites | ||
| Investigators ranked against your study criteria | ||
| Enrollment forecasting by country | ||
| Compare recommended countries with your own strategy | ||
| Surface emerging and underutilized investigators | ||
| Competitive trial activity and patient demand analysis |
Turn your patient cohort into a ranked shortlist of sites and investigators.
Sponsors and CROs working on study planning, feasibility, country selection, site selection and investigator identification. It supports more informed enrollment decisions using clinical intelligence, investigator performance data and enrollment forecasting.
Traditional site selection often relies on historical knowledge, existing investigator networks and fragmented data sources. Investigator SmartSelect combines investigator recommendations, enrollment forecasting and competitive intelligence in one workflow, so country, site and investigator decisions move faster and hold up under review.
Recommendations are generated from study-specific criteria: trial experience, recruitment potential, capacity, patient access and historical performance. Each recommendation includes visibility into the factors behind the ranking.
In back-testing across 16,000+ historical trials, the enrollment-rate forecast was 33% more accurate than a historical completed-trial benchmark.
Yes. Investigator SmartSelect works on its own and connects to the wider suite, taking criteria and cohorts forward from Protocol SmartDesign and Cohort SmartBuilder.
